Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial

التفاصيل البيبلوغرافية
العنوان:	Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial
المؤلفون:	Diver, Sarah ^, Khalfaoui, Latifa ^, Emson, Claire ^, Wenzel, Sally E, Menzies-Gow, Andrew, Wechsler, Michael E, Johnston, James, Molfino, Nestor, Parnes, Jane R, Megally, Ayman, Colice, Gene, Brightling, Christopher E ^
المصدر:	In The Lancet Respiratory Medicine November 2021 9(11):1299-1312
قاعدة البيانات:	ScienceDirect

الوصف
تدمد:	22132600
DOI:	10.1016/S2213-2600(21)00226-5